Monoclonal proliferation of double‐negative (CD4CD8) T‐cells bearing T‐Cell receptor‐αβ followed by subsequent development of Hodgkin's disease

Mitsuru Matsumoto, Kiyonori Takada, Takaaki Hato, Takahiko Horiuchi, Masaki Yasukawa, Shinichi Murao, Shigeru Fujita

Research output: Contribution to journalArticle

Abstract

Expression of CD4 or CD8 on the cell surface is an important guide for discriminating the immunologic functions of T‐cells. However, a minor T‐cell subset lacking both CD4 and CD8 molecules but bearing the usual form of T‐cell receptor (TCR)‐αβ (CD4CD8TCR‐αβ+ T‐cells) has recently been found not only in mice but also in humans, and the clinical relevance of this newly defined subpopulation to human diseases is now of considerable interest. The authors present a patient in whom CD4CD8TCR‐αβ+ T‐cells showed monoclonal proliferation in the peripheral blood for more than 3 years, then disappeared spontaneously, followed by subsequent development of Hodgkin's disease. The pathologic roles of double‐negative T‐cell proliferation in this case are discussed from the viewpoint of premalignancy in lymphoproliferative diseases. Cancer 1994; 73:2818–23.

Original languageEnglish
Pages (from-to)2818-2823
Number of pages6
JournalCancer
Volume73
Issue number11
DOIs
Publication statusPublished - Jun 1 1994
Externally publishedYes

Fingerprint

Hodgkin Disease
CD4 Antigens
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Monoclonal proliferation of double‐negative (CD4CD8) T‐cells bearing T‐Cell receptor‐αβ followed by subsequent development of Hodgkin's disease. / Matsumoto, Mitsuru; Takada, Kiyonori; Hato, Takaaki; Horiuchi, Takahiko; Yasukawa, Masaki; Murao, Shinichi; Fujita, Shigeru.

In: Cancer, Vol. 73, No. 11, 01.06.1994, p. 2818-2823.

Research output: Contribution to journalArticle

Matsumoto, Mitsuru ; Takada, Kiyonori ; Hato, Takaaki ; Horiuchi, Takahiko ; Yasukawa, Masaki ; Murao, Shinichi ; Fujita, Shigeru. / Monoclonal proliferation of double‐negative (CD4CD8) T‐cells bearing T‐Cell receptor‐αβ followed by subsequent development of Hodgkin's disease. In: Cancer. 1994 ; Vol. 73, No. 11. pp. 2818-2823.
@article{36762ebe2ba9460793638ab87f8a40e4,
title = "Monoclonal proliferation of double‐negative (CD4−CD8−) T‐cells bearing T‐Cell receptor‐αβ followed by subsequent development of Hodgkin's disease",
abstract = "Expression of CD4 or CD8 on the cell surface is an important guide for discriminating the immunologic functions of T‐cells. However, a minor T‐cell subset lacking both CD4 and CD8 molecules but bearing the usual form of T‐cell receptor (TCR)‐αβ (CD4−CD8−TCR‐αβ+ T‐cells) has recently been found not only in mice but also in humans, and the clinical relevance of this newly defined subpopulation to human diseases is now of considerable interest. The authors present a patient in whom CD4−CD8−TCR‐αβ+ T‐cells showed monoclonal proliferation in the peripheral blood for more than 3 years, then disappeared spontaneously, followed by subsequent development of Hodgkin's disease. The pathologic roles of double‐negative T‐cell proliferation in this case are discussed from the viewpoint of premalignancy in lymphoproliferative diseases. Cancer 1994; 73:2818–23.",
author = "Mitsuru Matsumoto and Kiyonori Takada and Takaaki Hato and Takahiko Horiuchi and Masaki Yasukawa and Shinichi Murao and Shigeru Fujita",
year = "1994",
month = "6",
day = "1",
doi = "10.1002/1097-0142(19940601)73:11<2818::AID-CNCR2820731126>3.0.CO;2-L",
language = "English",
volume = "73",
pages = "2818--2823",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Monoclonal proliferation of double‐negative (CD4−CD8−) T‐cells bearing T‐Cell receptor‐αβ followed by subsequent development of Hodgkin's disease

AU - Matsumoto, Mitsuru

AU - Takada, Kiyonori

AU - Hato, Takaaki

AU - Horiuchi, Takahiko

AU - Yasukawa, Masaki

AU - Murao, Shinichi

AU - Fujita, Shigeru

PY - 1994/6/1

Y1 - 1994/6/1

N2 - Expression of CD4 or CD8 on the cell surface is an important guide for discriminating the immunologic functions of T‐cells. However, a minor T‐cell subset lacking both CD4 and CD8 molecules but bearing the usual form of T‐cell receptor (TCR)‐αβ (CD4−CD8−TCR‐αβ+ T‐cells) has recently been found not only in mice but also in humans, and the clinical relevance of this newly defined subpopulation to human diseases is now of considerable interest. The authors present a patient in whom CD4−CD8−TCR‐αβ+ T‐cells showed monoclonal proliferation in the peripheral blood for more than 3 years, then disappeared spontaneously, followed by subsequent development of Hodgkin's disease. The pathologic roles of double‐negative T‐cell proliferation in this case are discussed from the viewpoint of premalignancy in lymphoproliferative diseases. Cancer 1994; 73:2818–23.

AB - Expression of CD4 or CD8 on the cell surface is an important guide for discriminating the immunologic functions of T‐cells. However, a minor T‐cell subset lacking both CD4 and CD8 molecules but bearing the usual form of T‐cell receptor (TCR)‐αβ (CD4−CD8−TCR‐αβ+ T‐cells) has recently been found not only in mice but also in humans, and the clinical relevance of this newly defined subpopulation to human diseases is now of considerable interest. The authors present a patient in whom CD4−CD8−TCR‐αβ+ T‐cells showed monoclonal proliferation in the peripheral blood for more than 3 years, then disappeared spontaneously, followed by subsequent development of Hodgkin's disease. The pathologic roles of double‐negative T‐cell proliferation in this case are discussed from the viewpoint of premalignancy in lymphoproliferative diseases. Cancer 1994; 73:2818–23.

UR - http://www.scopus.com/inward/record.url?scp=0028238848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028238848&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19940601)73:11<2818::AID-CNCR2820731126>3.0.CO;2-L

DO - 10.1002/1097-0142(19940601)73:11<2818::AID-CNCR2820731126>3.0.CO;2-L

M3 - Article

C2 - 8194023

AN - SCOPUS:0028238848

VL - 73

SP - 2818

EP - 2823

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 11

ER -